Endotoxemia is associated with the principal causes of death in adult horses and equine neonates and, therefore, veterinary researchers are expending efforts to identify new therapeutic interventions that might be beneficial in these animals. Endotoxin antagonists inhibit interaction of endotoxin with cellular receptors and may be beneficial in the treatment of endotoxemia and sepsis. Diphosphoryl lipid A from Rhodobacter sphaeroides (RsDPLA) is a potent antagonist of enteric LPS in human cells, but is an agonist in hamster cells. In this study, the effect of lipopolysaccharide from R. sphaeroides (RsLPS) on equine whole blood and isolated monocyte preparations was investigated by comparing tumor necrosis factor (TNF) production in response to RsLPS and Escherichia coli O55:B5 LPS. Our results indicate that RsLPS is a potent agonist in equine cells, which precludes therapeutic use of this agent in equine patients. In contrast to the results in equine cells, RsLPS did not elicit TNF production by itself, and inhibited the response to E. coli O55:B5 LPS in a human monocytic cell line.
References
1.
Moore JNRecognition and treatment of endotoxemia. Vet Clin North Am Equine Pract1988; 4: 105—113.
2.
Moore JN, Morris DDEndotoxemia and septicemia in horses: experimental and clinical correlates . J Am Vet Med Assoc1992; 200: 1903—1914.
3.
Bailey SR, Elliott J.The role of prostanoids and nitric oxide in endotoxin-induced hyporesponsiveness of equine digital blood vessels. Equine Vet J1999; 31: 212—218.
4.
Welch RD, Watkins JP, Taylor TS, Cohen ND, Carter GKDisseminated intravascular coagulation associated with colic in 23 horses (1984—1989). J Vet Intern Med1992; 6: 29—35.
5.
Morris DDEndotoxemia in horses. A review of cellular and humoral mediators involved in its pathogenesis. J Vet Intern Med1991 ; 5: 167—181.
6.
Bradley SGCellular and molecular mechanisms of action of bacterial endotoxins. Annu Rev Microbiol1979; 33: 67—94.
7.
Rietschel ET, Brade H., Holst O. et al. Bacterial endotoxin: chemical constitution, biological recognition, host response and immunological detoxification. In: Rietschel ET, Wagner H. (eds) Pathology of Septic Shock. Berlin: Springer, 1996; 39—81.
8.
Zahringer U. , Lindner B., Rietschel ETMolecular structure of lipid A, the endotoxic center of bacterial lipopolysaccharides. Adv Carbohydr Chem Biochem1994; 50: 211—276.
9.
Galanos C., Luderitz O., Rietschel ET et al. Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities. Eur J Biochem1985; 148: 1—5.
10.
Mueller-Loennies S., Zaehringer U., Seydel U., Kusumoto S., Ulmer AJ, Rietschel ETWhat we know and don't know about chemical and physical structure of lipopolysaccharide in relation to biological activity . In: Levin J, Pollack M, Yokochi T, Nakano M. (eds) Endotoxin and Sepsis, vol. 397. New York: Wiley-Liss, 1996; 51—71.
11.
Schumann RR , Leong SR, Flaggs GW et al. Structure and function of lipopolysaccharide binding protein. Science1990; 249: 1429—1431.
12.
Ulevitch RJ , Tobias PSReceptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol1995 ; 13: 437—457.
Shimazu R., Akashi S., Ogata H. et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med1999; 189: 1777—1782.
Strittmatter W., Weckesser J., Salimath PV, Galanos C.Nontoxic lipopolysaccharide from Rhodopseudomonas sphaeroides ATCC 17023. J Bacteriol1983; 155: 153—158.
17.
Lei MG, Qureshi N., Morrison DCLipopolysaccharide (LPS) binding to 73-kDa and 38-kDa surface proteins on lymphoreticular cells: preferential inhibition of LPS binding to the former by Rhodopseudomonas sphaeroides lipid A. Immunol Lett1993; 36: 245—250.
18.
Golenbock DT , Hampton RY, Qureshi N., Takayama K., Raetz CRLipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J Biol Chem1991; 266: 19490—19498.
19.
Manthey CL, Perera PY, Qureshi N., Stutz PL, Hamilton TA, Vogel SNModulation of lipopolysaccharide-induced macrophage gene expression by Rhodobacter sphaeroides lipid A and SDZ 880.431. Infect Immun1993; 61: 3518—3526.
20.
Zuckerman SH , Qureshi N.In vivo inhibition of liposaccharideinduced lethality and tumor factor synthesis by Rhodobacter sphaeroides diphosphoryl lipid A is dependent on corticosterone induction. Infect Immun1992; 60: 2581—2587.
21.
Delude RL, Savedra Jr R., Zhao H. et al. CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. Proc Natl Acad Sci USA1995; 92: 9288—9292.
22.
Lien E., Means TK, Heine H. et al. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J Clin Invest2000; 105: 497—504.
23.
Henry MM, Moore JNEndotoxin-induced procoagulant activity in equine peripheral blood monocytes . Circ Shock1988; 26: 297—309.
24.
Morris DD, Moore JN, Fischer K., Tarleton RLEndotoxin-induced tumour necrosis factor activity production by equine peritoneal macrophages. Circ Shock1990; 30: 229—236.
25.
Siriwardena A., Jorgensen MR, Wolfert MA, Vandenplas ML, Moore JN, Boons GJSynthesis and proinflammatory effects of peptidoglycan-derived neoglycopeptide polymers. J Am Chem Soc2001 ; 123: 8145—8146.
26.
Rossignol DP, Hawkins DL, Christ WJ et al. Synthetic endotoxin antagonists. In: Brade H, Opal SM, Vogel SN, Morrison DC. (eds) Endotoxin in Health and Disease. Basel: Marcel Dekker, 1999; 699—719.
27.
Hajjar AM, Ernst RK, Tsai JH, Wilson CB, Miller SIHuman Human Toll-like receptor 4 recognises host-specific LPS modifications . Nat Immunol2002; 3: 354—359.
28.
Akashi S., Nagai Y., Ogata H. et al. Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition. Int Immunol2001; 13: 1595—1599.
29.
Muroi M., Ohnishi T., Tanamoto K.MD-2, a novel accessory molecule, is involved in species-specific actions of Salmonella lipid A. Infect Immun2002; 70: 3546—3550.
